BridgeMD
New treatment option for Vitiligo
Official title Betamethasone Phonophoresis For Vitiligo
ClinicalTrials.gov ID: NCT07267273
What this study is testing
What is Beclomethasone?
Beclomethasone is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for vitiligo.
Also referred to as phonophoresis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Vitiligo is a skin disorder that results in the formation of depigmented patches or hypopigmented macules due to selective destruction or reduction of melanocytes the cells that produce pigment in our skin. Vitiligo affects 0.1-2% of the World's population.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 40
You may be able to join if
- Male and female patients diagnosed with vitiligo.
- Medically and psychologically stable patients.
- Good cognitive abilities to understand the requirements of the study.
- All patients enrolled to the study will have their informed consent.
- they had no contraindications to the use of therapeutic ultrasound
You likely can't join if
- Pregnancy or lactation.
- Immunosuppression.
- Alcohol abuse.
- History of spontaneous re-pigmentation of lesions.
- Presence of skin characteristics that may interfere with study assessment.
- Active bacterial/viral infection.
See the full eligibility criteria
- Male and female patients diagnosed with vitiligo.
- Medically and psychologically stable patients.
- Good cognitive abilities to understand the requirements of the study.
- All patients enrolled to the study will have their informed consent.
- they had no contraindications to the use of therapeutic ultrasound
- Pregnancy or lactation.
- Immunosuppression.
- Alcohol abuse.
- History of spontaneous re-pigmentation of lesions.
- Presence of skin characteristics that may interfere with study assessment.
- Active bacterial/viral infection.
- Patients on other immune suppressants and phototherapy
- Patients currently participating in any other clinical study
- Uncooperative patients.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.